Published in Invest Ophthalmol Vis Sci on March 30, 2011
Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction | NCT03767530
The use of fluorescent quenching in studying the contribution of evaporation to tear thinning. Invest Ophthalmol Vis Sci (2012) 1.64
Emerging treatment options for meibomian gland dysfunction. Clin Ophthalmol (2013) 1.02
Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis (2011) 0.97
Meibomian gland dysfunction determines the severity of the dry eye conditions in visual display terminal workers. PLoS One (2014) 0.92
Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction. Clin Ophthalmol (2014) 0.91
Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction. Clin Ophthalmol (2013) 0.88
Objective image analysis of the meibomian gland area. Br J Ophthalmol (2013) 0.86
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol (2016) 0.85
The combined effect of azithromycin and insulin-like growth factor-1 on cultured human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci (2014) 0.85
Waved with open eyelids 2 (woe2) is a novel spontaneous mouse mutation in the protein phosphatase 1, regulatory (inhibitor) subunit 13 like (Ppp1r13l) gene. BMC Genet (2012) 0.84
How to promote and preserve eyelid health. Clin Ophthalmol (2012) 0.84
Meibography: A review of techniques and technologies. Saudi J Ophthalmol (2012) 0.84
Interventions for chronic blepharitis. Cochrane Database Syst Rev (2012) 0.83
Biophysical and morphological evaluation of human normal and dry eye meibum using hot stage polarized light microscopy. Invest Ophthalmol Vis Sci (2014) 0.83
Korean guidelines for the diagnosis and management of dry eye: development and validation of clinical efficacy. Korean J Ophthalmol (2014) 0.82
Association Between Serum Levels of Testosterone and Estradiol With Meibomian Gland Assessments in Postmenopausal Women. Invest Ophthalmol Vis Sci (2016) 0.82
The influence of 13-cis retinoic acid on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci (2013) 0.81
Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study. Int Ophthalmol (2014) 0.81
Neurotransmitter influence on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci (2011) 0.80
Image-guided evaluation and monitoring of treatment response in patients with dry eye disease. Graefes Arch Clin Exp Ophthalmol (2014) 0.80
Evaluation of the efficacy, safety, and acceptability of an eyelid warming device for the treatment of meibomian gland dysfunction. Clin Ophthalmol (2014) 0.80
Bioengineered Lacrimal Gland Organ Regeneration in Vivo. J Funct Biomater (2015) 0.80
Understanding Neuropathic Corneal Pain-Gaps and Current Therapeutic Approaches. Semin Ophthalmol (2016) 0.79
Meibomian gland cells display a differentiation-dependent composition of desmosomes. Histochem Cell Biol (2016) 0.79
Validity of subjective assessment as screening tool for dry eye disease and its association with clinical tests. Int J Ophthalmol (2015) 0.79
Dyslipidemia and its association with meibomian gland dysfunction. Int Ophthalmol (2015) 0.79
Serum-induced keratinization processes in an immortalized human meibomian gland epithelial cell line. PLoS One (2015) 0.78
The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research. Invest Ophthalmol Vis Sci (2017) 0.78
Differential scanning calorimetric evaluation of human meibomian gland secretions and model lipid mixtures: transition temperatures and cooperativity of melting. Chem Phys Lipids (2013) 0.78
Assessment of signs of anterior blepharitis using standardized color photographs. Cornea (2013) 0.78
Epidemiology of Meibomian Gland Dysfunction in an Elderly Population. Cornea (2016) 0.77
A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction. Ophthalmol Ther (2014) 0.76
A unique lineage gives rise to the meibomian gland. Mol Vis (2016) 0.76
Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography. Eye Contact Lens (2016) 0.75
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease-A Prospective, Multicenter Noninterventional Study. J Ocul Pharmacol Ther (2015) 0.75
Effects of a New Eyelid Shampoo on Lid Hygiene and Eyelash Length in Patients with Meibomian Gland Dysfunction: A Comparative Open Study. J Ophthalmol (2016) 0.75
Meibomian Gland Dysfunction Correlates to the Tear Film Instability and Ocular Discomfort in Patients with Pterygium. Sci Rep (2017) 0.75
Effects of Systane(®) Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye. Clin Ophthalmol (2014) 0.75
Topical cyclosporin as an alternative treatment for vision threatening blepharokeratoconjunctivitis: a case report. Int Med Case Rep J (2012) 0.75
Risk Factors and Symptoms of Meibomian Gland Loss in a Healthy Population. J Ophthalmol (2016) 0.75
Prevalence and associated factors of dry eye: Our experience in patients above 40 years of age at a Tertiary Care Center. Oman J Ophthalmol (2016) 0.75
Update in oculoplastic imaging. Saudi J Ophthalmol (2012) 0.75
Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin. Clin Ophthalmol (2017) 0.75
Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment. Int Ophthalmol (2016) 0.75
Fibroblast Growth Factor Receptor 2 (FGFR2) Is Required for Meibomian Gland Homeostasis in the Adult Mouse. Invest Ophthalmol Vis Sci (2017) 0.75
Changes in meibomian gland morphology and ocular higher-order aberrations in eyes with chalazion. Clin Ophthalmol (2017) 0.75
Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review. Ophthalmol Ther (2017) 0.75
A novel noninvasive ocular surface analyzer for the assessment of dry eye with Meibomian gland dysfunction. Exp Ther Med (2017) 0.75
Meibomian gland function and giant papillary conjunctivitis. Am J Ophthalmol (1992) 2.22
Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol (1995) 2.21
Classification of chronic blepharitis. Ophthalmology (1982) 1.97
Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci (1997) 1.65
Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology (1993) 1.56
Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology (1998) 1.49
Meibomian gland dysfunction in chronic blepharitis. Cornea (1991) 1.45
Meibomian keratoconjunctivitis. Am J Ophthalmol (1977) 1.43
Meibomian gland lipids, evaporation, and tear film stability. Adv Exp Med Biol (1998) 1.39
Meibomian gland disease. Classification and grading of lid changes. Eye (Lond) (1991) 1.36
Contact lens wear is associated with decrease of meibomian glands. Ophthalmology (2009) 1.36
The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci (2003) 1.34
The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci (1991) 1.31
Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol (2002) 1.30
Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology (2009) 1.28
Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol (1998) 1.27
Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea (1992) 1.25
Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc (1980) 1.24
Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands. Arch Dermatol Res (1980) 1.22
Histopathology of meibomian gland dysfunction. Am J Ophthalmol (1982) 1.21
Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther (2008) 1.21
Polar lipids in human meibomian gland secretions. Curr Eye Res (2003) 1.19
The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction. Mol Vis (2008) 1.18
Meibomian gland studies: histologic and ultrastructural investigations. Invest Ophthalmol Vis Sci (1981) 1.16
Assessment of meibomian gland function in dry eye using meibometry. Arch Ophthalmol (1999) 1.16
Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology (2002) 1.11
Seborrhoeic blepharo-kerato-conjunctivitis. Trans Ophthalmol Soc U K (1967) 1.09
In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Invest Ophthalmol Vis Sci (1982) 1.09
Role of wax ester fatty alcohols in chronic blepharitis. Invest Ophthalmol Vis Sci (1993) 1.07
Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea (2006) 1.07
Rose bengal staining and cytologic characteristics associated with lipid tear deficiency. Am J Ophthalmol (1997) 1.05
Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol (2002) 1.04
Clinical practice. Seborrheic dermatitis. N Engl J Med (2009) 0.97
[Histopathological study of the meibomian glands in 72 autopsy cases]. Nippon Ganka Gakkai Zasshi (1994) 0.91
Comparison of the kinetics of sebum secretion in young women with and without acne. Dermatologica (1991) 0.88
The sebaceous gland and acne--40 years on. Dermatology (1998) 0.88
Where is the gray line? Arch Ophthalmol (1987) 0.85
An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci (2010) 2.29
The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci (2011) 2.28
Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis. Ophthalmology (2006) 2.14
Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus. Am J Ophthalmol (2004) 2.06
Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol (2011) 1.94
Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea (2012) 1.82
New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology (2007) 1.71
Time to resolution of contact lens-induced corneal warpage prior to refractive surgery. CLAO J (2002) 1.69
Lipids of human meibum: mass-spectrometric analysis and structural elucidation. J Lipid Res (2007) 1.64
Intraocular lens power calculation after myopic laser in situ keratomileusis: Estimating the corneal refractive power. J Cataract Refract Surg (2008) 1.57
Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol (2012) 1.53
Mathematical projection model of visual loss due to fuchs corneal dystrophy. Invest Ophthalmol Vis Sci (2011) 1.53
Cytokeratin 15 can be used to identify the limbal phenotype in normal and diseased ocular surfaces. Invest Ophthalmol Vis Sci (2006) 1.53
Comparative higher-order aberration measurement of the LADARWave and Visx WaveScan aberrometers at varying pupil sizes and after pharmacologic dilation and cycloplegia. J Cataract Refract Surg (2006) 1.45
The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol (2010) 1.43
Liquid chromatography-mass spectrometric analysis of lipids present in human meibomian gland secretions. Lipids (2007) 1.43
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study. Int J Urol (2013) 1.41
Tear function and ocular surface findings in premature and term babies. Ophthalmology (2004) 1.41
Microkeratome-assisted phacoemulsification. J Cataract Refract Surg (2005) 1.38
Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea (2011) 1.38
Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci (2005) 1.34
Corneal sensitivity and slit scanning in vivo confocal microscopy of the subbasal nerve plexus of the normal central and peripheral human cornea. Cornea (2009) 1.31
Northern New Zealand Rhegmatogenous Retinal Detachment Study: epidemiology and risk factors. Clin Experiment Ophthalmol (2004) 1.23
Serum-free spheroid culture of mouse corneal keratocytes. Invest Ophthalmol Vis Sci (2005) 1.20
Polar lipids in human meibomian gland secretions. Curr Eye Res (2003) 1.19
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology (2005) 1.15
Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis. Ophthalmology (2002) 1.14
Carbon-ion radiation therapy for prostate cancer. Int J Urol (2012) 1.13
A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol (2006) 1.13
Spectroscopic evaluation of human tear lipids. Chem Phys Lipids (2007) 1.12
Development and validation of a short global dry eye symptom index. Ocul Surf (2007) 1.12
Temperature-induced conformational changes in human tearlipids hydrocarbon chains. Biopolymers (2007) 1.12
Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology (2002) 1.11
Association between meibomian gland changes and aging, sex, or tear function. Cornea (2006) 1.10
The role of oxidative stress and inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci (2009) 1.09
The contribution of the posterior surface to the corneal aberrations in eyes after keratoplasty. Invest Ophthalmol Vis Sci (2011) 1.08
Comparative study of descemet stripping automated endothelial keratoplasty donor preparation by Moria CBm microkeratome, horizon microkeratome, and Intralase FS60. Cornea (2011) 1.07
Long-term outcome of cultivated oral mucosal epithelial sheet transplantation in treatment of total limbal stem cell deficiency. Ophthalmology (2011) 1.07
Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea (2006) 1.07
The impact of nasal conjunctivochalasis on tear functions and ocular surface findings. Am J Ophthalmol (2007) 1.06
Updates in Acanthamoeba keratitis. Eye Contact Lens (2007) 1.05
Corneal higher-order aberrations after Descemet's stripping automated endothelial keratoplasty. Ophthalmology (2010) 1.05
Evaluation of lipid oxidative stress status in Sjögren syndrome patients. Invest Ophthalmol Vis Sci (2013) 1.04
Therapeutic deep lamellar keratoplasty for cornea perforation. Am J Ophthalmol (2003) 1.04
Increased evaporative rates in laboratory testing conditions simulating airplane cabin relative humidity: an important factor for dry eye syndrome. Eye Contact Lens (2007) 1.04
Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci (2011) 1.04
The effects of 2 week senofilcon-A silicone hydrogel contact lens daily wear on tear functions and ocular surface health status. Cont Lens Anterior Eye (2010) 1.04
Atopic ocular surface disease: implications on tear function and ocular surface mucins. Cornea (2005) 1.04
Age-related dysfunction of the lacrimal gland and oxidative stress: evidence from the Cu,Zn-superoxide dismutase-1 (Sod1) knockout mice. Am J Pathol (2012) 1.03
Characterization of human meibum lipid using raman spectroscopy. Curr Eye Res (2009) 1.03
MUC1 splice variants in human ocular surface tissues: possible differences between dry eye patients and normal controls. Exp Eye Res (2006) 1.03
Characteristics of traumatic globe rupture after keratoplasty. Ophthalmology (2009) 1.02
Complete spontaneous crystalline lens dislocation into the anterior chamber with severe corneal endothelial cell loss. Cornea (2007) 1.00
Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty. Adv Ther (2012) 1.00
Meibomianitis: polar lipid abnormalities. Cornea (2004) 1.00
Comparison of deep lamellar keratoplasty and penetrating keratoplasty for lattice and macular corneal dystrophies. Am J Ophthalmol (2006) 0.99
The use of human mesenchymal stem cell-derived feeder cells for the cultivation of transplantable epithelial sheets. Invest Ophthalmol Vis Sci (2009) 0.99
Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency. Arch Ophthalmol (2007) 0.98
Changes in human meibum lipid with meibomian gland dysfunction using principal component analysis. Exp Eye Res (2010) 0.98
Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology (2002) 0.97
Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Curr Eye Res (2007) 0.96
In vivo confocal microscopy through-focusing to measure corneal flap thickness after laser in situ keratomileusis. J Cataract Refract Surg (2002) 0.96
Analysis of the composition of lipid in human meibum from normal infants, children, adolescents, adults, and adults with meibomian gland dysfunction using ¹H-NMR spectroscopy. Invest Ophthalmol Vis Sci (2011) 0.96
Melanocytes in the corneal limbus interact with K19-positive basal epithelial cells. Exp Eye Res (2005) 0.96
Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure. Cytokine (2008) 0.96
Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2006) 0.95
Cataract surgery combined with ocular surface reconstruction in patients with severe cicatricial keratoconjunctivitis. J Cataract Refract Surg (2002) 0.95
The Auckland cataract study: co-morbidity, surgical techniques, and clinical outcomes in a public hospital service. Br J Ophthalmol (2002) 0.95
Avellino corneal dystrophy worsening after laser in situ keratomileusis: further clinicopathologic observations and proposed pathogenesis. Am J Ophthalmol (2008) 0.95
Comparison of the corneal response to laser in situ keratomileusis with flap creation using the FS15 and FS30 femtosecond lasers: clinical and confocal microscopy findings. J Cataract Refract Surg (2007) 0.95
Endoscopy-guided vitreoretinal surgery following penetrating corneal injury: a case report. Clin Ophthalmol (2010) 0.95
Collagen-immobilized poly(vinyl alcohol) as an artificial cornea scaffold that supports a stratified corneal epithelium. J Biomed Mater Res B Appl Biomater (2006) 0.95
Pterygium surgery: conjunctival autograft using a fibrin adhesive. Cornea (2006) 0.94
Physical changes in human meibum with age as measured by infrared spectroscopy. Ophthalmic Res (2010) 0.94
Disposable eyelid-warming device for the treatment of meibomian gland dysfunction. Jpn J Ophthalmol (2003) 0.94
The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice. Invest Ophthalmol Vis Sci (2013) 0.94
Laser in situ keratomileusis for residual refractive errors after apodized diffractive multifocal intraocular lens implantation. J Cataract Refract Surg (2009) 0.93
Confocal assessment of the corneal response to intracorneal lens insertion and laser in situ keratomileusis with flap creation using IntraLase. J Cataract Refract Surg (2006) 0.93
Quality of life changes after myopic wavefront-guided laser in situ keratomileusis. Eye Contact Lens (2009) 0.93
Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions. Int J Radiat Oncol Biol Phys (2012) 0.93
Corneal opacity and cataract: triple procedure versus secondary approach. Cornea (2003) 0.93
Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation. Am J Ophthalmol (2011) 0.92
Corneal deturgescence after Descemet stripping automated endothelial keratoplasty evaluated by Visante anterior segment optical coherence tomography. Am J Ophthalmol (2009) 0.92
Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Cornea (2013) 0.92
Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: a new potentially blinding syndrome. Ophthalmology (2006) 0.91
Proliferation and differentiation of transplantable rabbit epithelial sheets engineered with or without an amniotic membrane carrier. Invest Ophthalmol Vis Sci (2007) 0.91
Subepithelial corneal fibrosis partially due to epithelial-mesenchymal transition of ocular surface epithelium. Mol Vis (2010) 0.91
A novel NIH/3T3 duplex feeder system to engineer corneal epithelial sheets with enhanced cytokeratin 15-positive progenitor populations. Tissue Eng Part A (2008) 0.90
Symptoms, visual function, and mucin expression of eyes with tear film instability. Cornea (2013) 0.90
MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients. Exp Eye Res (2008) 0.90
Porous silk fibroin film as a transparent carrier for cultivated corneal epithelial sheets. J Biomater Sci Polym Ed (2011) 0.90
Functional visual acuity in Stevens-Johnson syndrome. Am J Ophthalmol (2006) 0.90
Immunohistochemistry and electron microscopy of retrocorneal scrolls in syphilitic interstitial keratitis. Curr Eye Res (2007) 0.89
In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients. Ophthalmology (2012) 0.89
Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation. Int J Pharm (2006) 0.89
The TFOS International Workshop on Contact Lens Discomfort: executive summary. Invest Ophthalmol Vis Sci (2013) 0.89
Factors affecting evaporation rates of tear film components measured in vitro. Eye Contact Lens (2009) 0.89